Pcf Research Awards Standing Review Committee Members

About Pcf Research Awards Standing Review Committee Members

PCF Leadership

  • Jonathan Simons, MD, President and CEO
  • Stuart Holden, MD, Medical Director
  • Howard Soule, PhD, Chief Science Officer and Executive Vice President
  • Andrea Miyahira, PhD, Manager, Scientific Programs
  • Development & Translation Committee, PCF Board of Directors

Surgical Urologic Oncology

  • William Aronson, MD, University of California, Los Angeles
  • Neil Bander, MD, Weill Cornell Medical College
  • Christopher Barbieri, MD, PhD, Weill Cornell Medical College
  • Brett Carver, MD, Memorial Sloan Kettering Cancer Center
  • H. Ballentine Carter, MD, Johns Hopkins University
  • Matthew Cooperberg, MD, University of California, San Francisco
  • Adam Feldman, MD, Massachusetts General Hospital
  • Stephen Freedland, MD, Cedars Sinai Medical Center
  • Isla Garraway, MD, PhD, University of California, Los Angeles
  • Martin Gleave, MD, The Vancouver Prostate Centre
  • Laurence Klotz, MD, University of Toronto
  • Todd Morgan, MD, University of Michigan
  • Joel Nelson, MD, University of Pittsburgh
  • Paul Nguyen, MD, Dana-Farber Cancer Institute
  • Robert Reiter, MD, University of California, Los Angeles
  • Martin Sanda, MD, Emory University
  • Edward Schaeffer, MD, PhD, Northwestern University
  • Ashutosh Tewari, MBBS, Icahn School of Medicine at Mount Sinai

Medical Oncology and Treatment Sciences

  • Joshi Alumkal, MD, Oregon Health & Science University
  • Emmanuel Antonarakis, MD, Johns Hopkins University
  • Andrew Armstrong, MD, Duke University
  • Gerhardt Attard, MD, PhD, The Royal Marsden Hospital
  • Tomasz Beer, MD, FACP, Oregon Health and Science University
  • Himisha Beltran, MD, Weill Cornell Medical College
  • Myles Brown, MD, Dana-Farber Cancer Institute
  • Yu Chen, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Atish Choudhury, MD, PhD, Dana-Farber Cancer Institute
  • William Dahut, MD, Weill Cornell Medical College
  • Johann de Bono, MD, PhD, The Royal Marsden Hospital
  • Samuel Denmeade, MD, Johns Hopkins University
  • Eleni Efstathiou, MD, PhD, The University of Texas MD Anderson Cancer Center
  • Terence Friedlander, MD, University of California, San Francisco
  • Matthew Galsky, MD, Icahn School of Medicine at Mount Sinai
  • Daniel George, MD, Duke University
  • Stephen Gruber, MD, PhD, University of Southern California
  • Daniel Haber, MD, PhD, Massachusetts General Hospital
  • Hans Hammers, MD, PhD, Johns Hopkins University
  • Lauren Harshman, MD, Dana-Farber Cancer Institute
  • Elisabeth Heath, MD, Wayne State University
  • Celestia Higano, MD, University of Washington
  • Andrew Hsieh, MD, Fred Hutchinson Cancer Research Center
  • Maha Hussain, MD, University of Michigan
  • Philip Kantoff, MD, Memorial Sloan Kettering Cancer Center
  • Joshua Lang, MD, University of Wisconsin
  • Richard Lee, MD, PhD, Massachusetts General Hospital
  • Glenn Liu, MD, University of Wisconsin
  • Christopher Logothetis, MD, The University of Texas MD Anderson Cancer Center
  • Nicholas Mitsiades, MD, PhD, Baylor College of Medicine
  • Michael Morris, MD, Memorial Sloan Kettering Cancer Center
  • Elahe Mostaghel, MD, PhD, Fred Hutchinson Cancer Research Center
  • Peter Nelson, MD, Fred Hutchinson Cancer Research Center
  • William Oh, MD, Icahn School of Medicine at Mount Sinai
  • Akash Patnaik, MD, PhD, University of Chicago
  • Kenneth Pienta, MD, Johns Hopkins University
  • Roberto Pili, MD, Roswell Park Cancer Institute
  • Mark Pomerantz, MD, Dana-Farber Cancer Institute
  • Edwin Posadas, MD, FACP, Cedars-Sinai Medical Center
  • Ganesh Raj, MD, PhD, University of Texas Southwestern
  • Dana Rathkopf, MD, Memorial Sloan Kettering Cancer Center
  • Matthew Rettig, MD, University of California, Los Angeles
  • Sameek Roychowdhury, MD, PhD, Ohio State University
  • Charles Ryan, MD, University of California, San Francisco
  • Oliver Sartor, MD, Tulane University
  • Philip Saylor, MD, Massachusetts General Hospital
  • Howard Scher, MD, Memorial Sloan Kettering Cancer Center
  • Nima Sharifi, MD, Cleveland Clinic
  • Eric Small, MD, University of California, San Francisco
  • Matthew Smith, MD, PhD, Massachusetts General Hospital
  • Walter Stadler, MD, University of Chicago
  • Charles Swanton, FCRP, PhD, Translational Cancer Therapeutics Laboratory CR-UK London Research Institute
  • Christopher Sweeney, MBBS, Dana-Farber Cancer Institute
  • Scott Tagawa, MD, Weill Cornell Medical College
  • David Takeda, MD, PhD, Broad Institute of MIT and Harvard
  • Eliezer Van Allen, MD, Dana-Farber Cancer Institute
  • Timothy Yap, PhD, The Institute of Cancer Research
  • Evan Yu, MD, University of Washington
  • Yu Wang, PhD, New York University
  • George Wilding, MD, The University of Texas MD Anderson Cancer Center
  • Amado Zurita, MD, The University of Texas MD Anderson Cancer Center

Immunotherapy

  • James Allison, PhD, The University of Texas, MD Anderson Cancer Center
  • Nathaniel Brennen, PhD, Johns Hopkins University
  • Charles Drake, MD, PhD, Johns Hopkins University
  • Lawrence Fong, MD, University of California, San Francisco
  • James Gulley, MD, PhD, National Cancer Institute
  • Haydn Kissick, PhD, Emory University
  • Marcin Kortylewski, PhD, City of Hope
  • Douglas McNeel, MD, PhD, University of Wisconsin
  • Brian Olson, PhD, University of Wisconsin
  • Saul Priceman, PhD, City of Hope
  • William Redmond, PhD, Providence Portland Medical Center
  • Pam Sharma, MD, PhD, MD, The University of Texas MD Anderson Cancer Center
  • Jinjun Shi, PhD, Brigham and Women’s Hospital
  • Sumit Subudhi, MD, PhD, The University of Texas, MD Anderson Cancer Center

Genomics / Bioinformatics

  • John Carpten, PhD, University of Southern California
  • Marcin Cieslik, PhD, University of Michigan
  • Colin Collins, PhD, University of British Columbia
  • Michael Evans, PhD, University of California, San Francisco
  • Levi Garraway, MD, PhD, Dana-Farber Cancer Institute
  • Ted Goldstein, PhD, UC Santa Cruz
  • William Hahn, MD, PhD, Dana-Farber Cancer Institute
  • Hannelore Heemers, PhD, Cleveland Clinic
  • William Isaacs, PhD, Johns Hopkins University
  • Neema Jamshidi, MD, PhD, University of California, Los Angeles
  • Jun Luo, PhD, Johns Hopkins University
  • Christopher Maher, PhD, Washington University
  • Antonina Mitrofanova, PhD, Rutgers Cancer Institute of New Jersey
  • Colin Pritchard, MD, PhD, University of Washington
  • Nikolaus Schultz, PhD, Memorial Sloan Kettering Cancer Center
  • Barry Taylor, PhD, Memorial Sloan Kettering Cancer Center
  • Alexander Wyatt, PhD, Vancouver Prostate Centre

Basic Science

  • Cory Abate-Shen, PhD, Columbia University
  • Vivek Arora, PhD, Washington University
  • Irfan Asangani, PhD, University of Pennsylvania
  • Steven Balk, PhD, Beth Israel Deaconess Medical Center
  • Chad Brenner, PhD, University of Michigan
  • Qi Cao, PhD, The Methodist Hospital Research Institute
  • Dimple Chakravarty, PhD, Weill Cornell Medical College
  • Charles Chan, PhD, Stanford University
  • Chia-Yi Chu, PhD, Cedars-Sinai Medical Center
  • Scott Dehm, PhD, University of Minnesota
  • Leigh Ellis, PhD, Roswell Park Cancer Institute
  • Andrew Goldstein, MD, University of California, Los Angeles
  • Geraldine Gueron, PhD, Iquibicen-Conicet
  • Christopher Heaphy, PhD, Johns Hopkins University
  • John Isaacs, PhD, Johns Hopkins University
  • Christina Jamieson, PhD, University of California, San Diego
  • Candace Johnson, PhD, Roswell Park Cancer Institute
  • Anthony Michael Joshua, Kinghorn Cancer Centre
  • Michael Jung, PhD, University of California, Los Angeles
  • Kalpana Kannan, PhD, Baylor College of Medicine
  • Karen Knudsen, PhD, Thomas Jefferson University
  • Rajan Kulkarni, MD, PhD, University of California, Los Angeles
  • Natasha Kyprianou, PhD, University of Kentucky
  • Hung-Ming Lam, PhD, University of Washington
  • Lucia Languino, PhD, University of Massachusetts
  • Aaron LeBeau, PhD, University of Minnesota
  • Shyh-Dar Li, PhD, The University of British Columbia
  • Shawn Lupold, PhD, Johns Hopkins University
  • Everardo Macias, PhD, Cedars-Sinai Medical Center
  • Rohit Malik, PhD, University of Michigan
  • Ram Mani, PhD, University of Texas Southwestern Medical Center
  • Ian Mills, PhD, University of Oslo
  • Richard Mithen, PhD, Institute of Food Research, UK
  • David Mulholland, PhD, Icahn School of Medicine at Mount Sinai
  • Nora Navone, MD, PhD, The University of Texas MD Anderson Cancer Center
  • Niv Papo, PhD, Ben-Gurion University of the Negev
  • Antoinette Perry, PhD, University of Dublin, Trinity College
  • David Rowley, PhD, Baylor College of Medicine
  • Marianne Sadar, PhD, BC Cancer Agency
  • Anirban Sahu, MD, University of Michigan
  • Jack Schalken, PhD, University Hospital of Nijmegen
  • Matthew Schiewer, PhD, Thomas Jefferson University
  • Luke Selth, PhD, University of Adelaide
  • Karen Sfanos, PhD, Johns Hopkins University
  • Yusuke Shiozawa, MD, PhD, Wake Forest School of Medicine
  • Tanya Stoyanova, PhD, Stanford University
  • Russell Taichman, DMD, DMSc, University of Michigan
  • Muneesh Tewari, MD PhD, Fred Hutchinson Cancer Research Center
  • Timothy Thompson, PhD, The University of Texas MD Anderson Cancer Center
  • Li Wang, PhD, Icahn School of Medicine at Mount Sinai
  • Shaomeng Wang, PhD, University of Michigan
  • Yuzhuo Wang, PhD, BC Cancer Agency
  • Owen Witte, MD, University of California, Los Angeles
  • Hong Wu, MD, PhD, Peking University
  • Kexin Xu, PhD, University of Texas Health Science Center at San Antonio
  • Srinivasan Yegnasubramanian, MD, PhD, Johns Hopkins University
  • Amina Zoubeidi, PhD, University of British Columbia

Radiation Oncology

  • Robert Bristow, MD, PhD, University of Toronto
  • Robert Den, MD, Thomas Jefferson University
  • Theodore DeWeese, MD, Johns Hopkins University
  • Adam Dicker, MD, PhD, Thomas Jefferson University
  • Jason Efstathiou, MD, Massachusetts General Hospital
  • Felix Feng, MD, University of California, San Francisco
  • Steven Frank, MD, The University of Texas MD Anderson Cancer Center
  • Franklin Huang, MD, PhD, Dana-Farber Cancer Institute
  • Stanley Liauw, MD, University of Chicago
  • Neil Martin, MD, Brigham and Women’s Hospital
  • Howard Sandler, MD, Cedars-Sinai Medical Center
  • Nicole Simone, MD, Thomas Jefferson University
  • Daniel Spratt, MD, University of Michigan
  • Neha Vapiwala, MD, University of Pennsylvania
  • Scott Williams, MD, Peter MacCallum Cancer Centre

Radiology

  • Jeremy Durack, MD, Memorial Sloan Kettering Cancer Center

Molecular Imaging

  • Steve Cho, MD, Johns Hopkins University
  • Peter Choyke, MD, National Cancer Institute
  • Robert Jeraj, PhD, University of Wisconsin
  • John Kurhanewicz, PhD, University of California, San Francisco
  • Steven Larson, MD, Memorial Sloan Kettering Cancer Center
  • Martin Pomper, MD, PhD, Johns Hopkins University
  • Daniel Thorek, PhD, Johns Hopkins University
  • David Ulmert, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Lily Wu, MD, PhD, University of California, Los Angeles

Molecular Pathology

  • Gustavo Ayala, MD, University of Texas Health Science Center
  • Tarek Bismar, MD, University of Calgary
  • Arul Chinnaiyan, MD, PhD, University of Michigan
  • Angelo DeMarzo, MD, PhD, Johns Hopkins University
  • Stephen Finn, PhD, MBBS, University of Dublin, Trinity College
  • Michael Haffner, MD, Johns Hopkins University
  • Jiaoti Huang, MD, PhD, Duke University
  • Michael Ittmann, MD, PhD, Baylor College of Medicine
  • Beatrice Knudsen, MD, PhD, Cedars-Sinai Medical Center
  • Massimo Loda, MD, Dana-Farber Cancer Institute
  • Tamara Lotan, MD, Johns Hopkins University
  • Rohit Mehra, MD, University of Michigan
  • Mark Rubin, MD, Weill Cornell Medical College
  • Jeffrey Simko, MD, PhD, University of California, San Francisco
  • Scott Tomlins, MD, PhD, University of Michigan

Epidemiology / Observational Research

  • June Chan, ScD, University of California, San Francisco
  • Peter Gann, MD, ScD, University of Illinois
  • Susan Halabi, PhD, Duke University
  • David Heber, MD, University of California, Los Angeles
  • Sarah Holt, PhD, Fred Hutchinson Cancer Research Center
  • Corrine Joshu, PhD, Princess Margaret Hospital
  • Nancy Keating, MD, Harvard Medical School
  • Stacey Kenfield, ScD, University of California, San Francisco
  • Heather Montie, PhD, Philadelphia College of Osteopathic Medicine
  • Lorelei Mucci, ScD, MPH, Harvard School of Public Health
  • William Nelson, MD, PhD, Johns Hopkins University
  • Kathryn Penney, ScD, Dana-Farber Cancer Institute
  • Elizabeth Platz, ScD, MPH, Johns Hopkins University
  • Jennifer Rider, ScD, Boston University
  • Meir Stampfer, MD, Harvard School of Public Health
  • Janet Stanford, PhD, Fred Hutchinson Cancer Research Center
  • Bruce Trock, PhD, Johns Hopkins University
  • Kathryn Wilson, ScD, Harvard School of Public Health